Showing results (2281-2290 of 2,795) with videos related to
Sort By:
Pageof 280
Plos One|October 4, 2011
Biochemical, structural and molecular dynamics analyses of the potential virulence factor RipA from Yersinia pestisRodrigo Torres, Robert V Swift, Nicholas Chim, et al.Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.The American Journal of Pathology|December 6, 2008
Development of a Rab9 transgenic mouse and its ability to increase the lifespan of a murine model of Niemann-Pick type C diseaseTatiana Kaptzan, Sally A West, Eileen L Holicky, et al.BMJ (Clinical Research Ed.)|August 8, 2012
Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysisClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1Joshua E Reuss, Sara Kuruvilla, Nofisat Ismaila, et al.Scientific Reports|March 14, 2019
Engulfment, persistence and fate of Bdellovibrio bacteriovorus predators inside human phagocytic cells informs their future therapeutic potentialDhaarini Raghunathan, Paul M Radford, Christopher Gell, et al.Lancet (London, England)|September 21, 2002
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable AnginaK A A Fox, P A Poole-Wilson, R A Henderson, et al.Heart (British Cardiac Society)|April 20, 2006
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trialP A Poole-Wilson, S J Pocock, K A A Fox, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility studyRoger E Taylor, Andrew J Howman, Keith Wheatley, et al.Sensors (Basel, Switzerland)|June 2, 2021
A Bi-Spectral Microbolometer Sensor for Wildfire MeasurementDenis Dufour, Loïc Le Noc, Bruno Tremblay, et al.Pageof 280